Effect of Ghrelin on Decision-Making
Status: | Not yet recruiting |
---|---|
Conditions: | Healthy Studies, Obesity Weight Loss |
Therapuetic Areas: | Endocrinology, Other |
Healthy: | No |
Age Range: | 18 - 40 |
Updated: | 3/1/2019 |
Start Date: | October 2019 |
End Date: | February 2022 |
Contact: | Laura Page, MD |
Email: | laura.page@duke.edu |
Phone: | 919-684-5091 |
Effect of Ghrelin on Nutritional and Financial Decision-Making
This study evaluates the effect of the "hunger hormone" ghrelin on human decision-making.
Participants will be given an injection of ghrelin or saline on different study days and will
then be asked to make a series of computer-based decisions. The investigators hypothesize
that ghrelin will increase participant's preference for energy-dense foods and will also
increase impulsiveness in decision making.
Participants will be given an injection of ghrelin or saline on different study days and will
then be asked to make a series of computer-based decisions. The investigators hypothesize
that ghrelin will increase participant's preference for energy-dense foods and will also
increase impulsiveness in decision making.
Ghrelin is a hormone made by the stomach that stimulates hunger and feeding behavior. How
ghrelin affects human decision-making is poorly understood. This study will investigate the
effect of ghrelin on nutrition-related and time-based decisions in humans. Participants eye
movements will be tracked by a computer during the decision-making process.
ghrelin affects human decision-making is poorly understood. This study will investigate the
effect of ghrelin on nutrition-related and time-based decisions in humans. Participants eye
movements will be tracked by a computer during the decision-making process.
Inclusion Criteria:
- Ability to speak and understand English
- BMI of 18.0 - 24.9 kg/m2 or 30.0 - 50.0 kg/m2
Exclusion Criteria:
- Diagnosis of diabetes mellitus (including gestational diabetes)
- Active infections
- History of malignant or inflammatory conditions, such as rheumatoid arthritis and
inflammatory bowel disease
- History of myocardial infarction or congestive heart failure
- Active liver or kidney disease
- Uncontrolled hypertension
- Pituitary or adrenal disorders or neuroendocrine tumors
- History of anorexia nervosa, bulimia, or eating disorders not otherwise specified
(NOS); Score of "at risk" on the EAT-26 eating disorder screening tool
- Diagnosis of attention-deficient/hyperactivity disorder (ADHD)
- Malabsorptive gastrointestinal disease, gastroparesis, or history of gastrointestinal
surgery
- Pregnancy or lactation
- Requirement of daily medications that alter gastrointestinal function (including, but
not limited to, glucocorticoids, psychotropics, narcotics, and metoclopramide).
- Requirement of glasses for impaired vision (including reading glasses). Subjects who
wear contact lenses for vision correction will not be excluded.
- Insufficient visual acuity to read and interpret the decision stimuli
- Insufficient motor capabilities to press a button, move the joystick, or move their
eyes to indicate a response
We found this trial at
1
site
417 Chapel Drive
Durham, North Carolina 27708
Durham, North Carolina 27708
Principal Investigator: Jenny Tong, MD, MPH
Phone: 919-684-5091
Click here to add this to my saved trials